Court Opinion

ID: 5733922
Source: CourtListenerOpinion
Date Created: 2022-01-12 16:30:14.641803+00
Date Added: 2024-06-11T08:40:55.765068
License: Public Domain

Steuer, J.,
dissents in the following memorandum: I dissent on the ground that whether the compound that was processed by the plaintiff was a pharmaceutical, and so within the policy, was a question of fact and should have been submitted to the jury. There was very substantial evidence that, although all of the ingredients were also used at times as ingredients of pharmaceuticals, the resulting compound was not in that classification, and that plaintiff actually knew that the compound was as dangerous to mill as it in fact proved to be. The increase in risk was not technical but actual, and the chance taken was deliberate. Whether the hazard was increased may be open to question, but to say that reasonable minds could not differ on the question is to say that quite a few minds are not reasonable.